Self-emission noninvasive infrared spectrophotometer

• US 5,515,847 A
• Filed: 05/23/1994
• Issued: 05/14/1996
• Est. Priority Date: 01/28/1993
• Status: Expired due to Fees

• Current Assignee: Optiscan Pty Ltd.
• Original Assignee: Optiscan Pty Ltd.
• Inventors: Braig, James R., Herrera, Roger O., Sterling, Bernhard B., Goldberger, Daniel S.
• Primary Examiner(s): Sykes, Angela D.
• Assistant Examiner(s): WINAKUR, ERIC FRANK
• Application Number:
  US08/247,311
• Time in Patent Office: 722 Days
• Field of Search: 128/633, 128/664
• US Class Current: 600/316
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/14546 for measuring analytes not otherwise provided for, e.g. ions, cytochromes
• CPC Class Codes: A61B 5/1455 using optical sensors, e.g. spectral photometrical oximeters
• CPC Class Codes: A61B 5/6826 Finger
• CPC Class Codes: G01N 21/35 using infrared light G01N21/39 takes precedence
• CPC Class Codes: G01N 21/3581 using far infrared light; using Terahertz radiation

Abstract

A method and apparatus for monitoring glucose, ethyl alcohol and other blood constituents in a noninvasive manner. The measurements are made by monitoring infrared absorption of the desired blood constituent in the long infrared wavelength range where the blood constituent has a strong and distinguishable absorption spectrum. The long wavelength infrared energy emitted by the person as heat is monitored and the infrared absorption of particular constituents in the blood (such as glucose or blood alcohol) is measured at characteristic infrared absorption wavelengths for those constituents. The measurements are preferably synchronized with systole and diastole of the cardiac cycle so that the signal contribution caused by veins and tissues (which do not pulse) may be cancelled when a ratio of the detected signals is taken. The concentration of the blood constituents are then determined in accordance with a polynomial equation.

Claims

1. A noninvasive infrared spectrophotometer, comprising:

means for determining infrared absorption of at least one predetermined constituent of a person'"'"'s blood from infrared emissions generated and emitted by the person'"'"'s body; and

processing means for calculating a concentration of said at least one predetermined constituent from the infrared absorption determined by said determining means.

2. A noninvasive infrared spectrophotometer for determining a concentration of at least one predetermined constituent in a person'"'"'s blood, comprising:

means for detecting infrared energy generated and emitted by the person in a wavelength range including m different wavelengths of at least 2.0 μ

m, said infrared energy containing energy at each of said n wavelengths which is differently absorbed by said at least one predetermined constituent whereby each predetermined constituent readily absorbs infrared energy at at least one of said m wavelengths and minimally absorbs infrared energy at another of said m wavelengths, said detecting means outputting at least one detection signal representative of infrared energy at said m wavelengths which has been emitted by said person and selectively absorbed by said at least one predetermined constituent;

synchronizing means for synchronizing the detection of said infrared energy emitted by the person with the systolic and diastolic phases of a cardiac cycle of the person; and

means for determining the concentration of said at least one predetermined constituent of the person'"'"'s blood from said at least one detection signal.

3. A spectrophotometer as in claim 2, wherein said diastolic and systolic phases of the cardiac cycle of the person respectively contain diastolic and systolic time intervals, each time interval having a duration of approximately 0.1-10 msec, whereby infrared energy is detected by said detecting means during said diastolic and systolic time intervals.

4. A spectrophotometer as in claim 2, wherein said at least one predetermined constituent includes glucose, said one wavelength is approximately 9.1 μ

m and said another wavelength is approximately 10.5 μ

m.

5. A spectrophotometer as in claim 4, further comprising an analytical filter wheel including first and second bandpass filters disposed thereon, said analytical filter wheel being disposed between an arterial blood vessel of the person and said at least one infrared detector, said first bandpass filter passing infrared light in a narrow passband centered at approximately 9.1 μ

m, and said second bandpass filter passing infrared light in a narrow passband centered at approximately 10.5 μ

m.

6. A spectrophotometer as in claim 4, further comprising a first bandpass filter disposed between an arterial blood vessel of the person and said at least one infrared detector, said first bandpass filter passing infrared light in a narrow passband centered at approximately 9.1 μ

m, and a second bandpass filter disposed between the arterial blood vessel of the person and said at least one infrared detector, said second bandpass filter passing infrared light in a narrow passband centered at approximately 10.5 μ

m.

7. A spectrophotometer as in claim 2, wherein said at least one predetermined constituent includes ethyl alcohol, said one wavelength is approximately 3.4 μ

m and said another wavelength is approximately 4.8 μ

m.

8. A spectrophotometer as in claim 7, further comprising an analytical filter wheel including first and second bandpass filters disposed thereon, said analytical filter wheel being disposed between an arterial blood vessel of the person and said at least one infrared detector, said first bandpass filter passing infrared light in a narrow passband centered at approximately 3.4 μ

m, and said second bandpass filter passing infrared light in a narrow passband centered at approximately 4.8 μ

m.

9. A spectrophotometer as in claim 7, further comprising a first bandpass filter disposed between an arterial blood vessel of the person and said at least one infrared detector, said first bandpass filter passing infrared light in a narrow passband centered at approximately 3.4 μ

m, and a second bandpass filter disposed between the arterial blood vessel of the person and said at least one infrared detector, said second bandpass filter passing infrared light in a narrow passband centered at approximately 4.8 μ

m.

10. A spectrophotometer as in claim 2, wherein said synchronizing means includes a cardiac monitor and a plethysmograph sensor connected to well perfused tissue of the person, said cardiac monitor detecting said systolic and diastolic phases of the cardiac cycle of the person from outputs provided by said plethysmograph sensor.

11. A spectrophotometer as in claim 10, wherein said plethysmograph sensor comprises a pulsed light emitting diode which directs light through said well perfused tissue of the person and a photodetector which detects the light which has passed through said well perfused tissue of the person, and said cardiac monitor comprises processing means for processing a detection output of said photodetector to determine a phase of said cardiac cycle.

12. A spectrophotometer as in claim 2, wherein said concentration determining means forms a ratio R₁ =(Sys L1-Dias L1)/(Sys L2-Dias L2), where Sys L1 is a detected systolic phase signal at said one wavelength, Dias L1 is a detected diastolic phase signal at said one wavelength, Sys L2 is a detected systolic phase signal at said another wavelength, and Dias L2 is a detected diastolic phase signal at said another wavelength.

13. A spectrophotometer as in claim 12, wherein said concentration determining means calculates the concentration of said at least one predetermined constituent (n) of the person'"'"'s blood in accordance with the following equation:

##EQU2## where;

C.C._n is the concentration of said at least one predetermined constituent n;

B, C_x,y and D_z are empirically determined calibration coefficients;

m is the number of detection and reference wavelengths used;

p is the highest order of polynomial used; and

Ln is a natural log function.

14. A spectrophotometer as in claim 2, further comprising a chopper wheel which modulates said infrared energy emitted by the person to a frequency beyond baseband prior to detection by said detecting means, a preamplifier for amplifying said at least one detection signal output by said detecting means, a bandpass filter centered at said frequency beyond baseband which filters said at least one detection signal output by said detecting means, and a synchronous demodulator for demodulating said infrared energy from said frequency beyond baseband.

15. A method of noninvasively measuring a concentration of at least one predetermined constituent in a person'"'"'s blood, comprising the steps of:

detecting infrared emissions generated and emitted by a person'"'"'s body;

determining infrared absorption of at least one predetermined constituent of a person'"'"'s blood from said infrared emissions generated and emitted by the person'"'"'s body and detected in said detecting step; and

calculating the concentration of said at least one predetermined constituent from the infrared absorption determined in said determining step.

16. A method of noninvasively measuring a concentration of at least one predetermined constituent in a person'"'"'s blood, comprising the steps of:

detecting infrared energy generated and emitted by the person in a wavelength range including m different wavelengths of at least 2.0 μ

m, said infrared energy containing energy at each of said n wavelengths which is differently absorbed by said at least one predetermined constituent whereby each predetermined constituent readily absorbs infrared energy at at least one of said m wavelengths and minimally absorbs infrared energy at another of said m wavelengths, and outputting at least one detection signal representative of infrared energy at said m wavelengths which has been emitted by said person and selectively absorbed by said at least one predetermined constituent;

synchronizing the detection of said infrared energy emitted by the person with the systolic and diastolic phases of a cardiac cycle of the person; and

determining the concentration of said at least one predetermined constituent of the person'"'"'s blood from said at least one detection signal.

17. A method as in claim 16, wherein said diastolic and systolic phases of the cardiac cycle of the person respectively contain diastolic and systolic time intervals, said synchronizing step including the step of determining said diastolic and systolic time intervals, whereby said detecting step is performed during said systolic and diastolic time intervals.

18. A method as in claim 16, wherein said concentration determining step includes the step of forming a ratio R=(Sys L1-Dias L1)/(Sys L2-Dias L2), where Sys L1 is a detected systolic phase signal at said one wavelength, Dias L1 is a detected diastolic phase signal at said one wavelength, Sys L2 is a detected systolic phase signal at said another wavelength, and Dias L2 is a detected diastolic phase signal at said another wavelength.

19. A method as in claim 18, wherein said concentration determining step includes the step of calculating the concentration of said at least one predetermined constituent (n) of the person'"'"'s blood in accordance with the following equation:

##EQU3## where;

C.C._n is the concentration of said at least one predetermined constituent n;

B, C_x,y and D_z are empirically determined calibration coefficients;

m is the number of detection and reference wavelengths used;

p is the highest order of polynomial used; and

Ln is a natural log function.

20. A method as in claim 16, comprising the further steps of applying a pressure cuff to an appendage of the person and inflating said pressure cuff to a predetermined pressure in synchrony with the detection of infrared energy in said detecting step.

21. A noninvasive infrared spectrophotometer for determining a concentration of at least one predetermined constituent in a person'"'"'s blood, comprising:

means for detecting infrared energy generated and emitted by the person in a wavelength range including n different wavelengths of at least 2.0 μ

m, said infrared energy containing energy at each of said wavelengths which is differently absorbed by said at least one predetermined constituent whereby each predetermined constituent readily absorbs infrared energy at at least one of said n wavelengths and minimally absorbs infrared energy at another of said n wavelengths, said detecting means outputting at least one detection signal representative of infrared energy at said n wavelengths which has been emitted by said person and selectively absorbed by said at least one predetermined constituent; and

means for determining the concentration of said at least one predetermined constituent of the person'"'"'s blood from said at least one detection signal.

22. A method of noninvasively measuring a concentration of at least one predetermined constituent in a person'"'"'s blood, comprising the steps of:

detecting infrared energy generated and emitted by the person in a wavelength range including n different wavelengths of at least 2.0 μ

m, said infrared energy containing energy at each of said n wavelengths which is differently absorbed by said at least one predetermined constituent whereby each predetermined constituent readily absorbs infrared energy at at least one of said n wavelengths and minimally absorbs infrared energy at another of said n wavelengths, and outputting at least one detection signal representative of infrared energy at said n wavelengths which has been emitted by said person and selectively absorbed by said at least one predetermined constituent; and

determining the concentration of said at least one predetermined constituent of the person'"'"'s blood from said at least one detection signal.